COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT01289223
Brief Title: A Trial to Investigate the Efficacy of Bendamustine in Patients With Indolent Non-Hodgkin's Lymphoma (NHL) Refractory to Rituximab. (ROBIN)

First Submitted : February 2, 2011
First Submitted that Met QC Criteria : February 2, 2011
First Posted : February 3, 2011 (Estimate)

Last Update Submitted that Met QC Criteria : August 30, 2018
Last Update Posted : September 4, 2018